| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028825 Compositions and Methods for Studying and Treating Inflammatory Diseases and Disorders |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | US20090025645 Recombinant constructs and transgenic fluorescent ornamental fish therefrom |
| 01/29/2009 | DE102007035238A1 Biologisches Effektmonitoring mittels transgener Hydra Biological effect monitoring using transgenic Hydra |
| 01/29/2009 | CA2731399A1 Nanoparticle-mediated treatment for inflammatory diseases |
| 01/29/2009 | CA2722754A1 Modified plasminogen activator inhibitor type-1 molecule and methods based thereon |
| 01/29/2009 | CA2720628A1 Fusion proteins |
| 01/29/2009 | CA2709412A1 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 01/29/2009 | CA2707372A1 Fatty acid compositions having novel fatty acid rate |
| 01/29/2009 | CA2694481A1 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694406A1 Baculoviral vectors comprising repeated coding sequences with differential codon biases |
| 01/29/2009 | CA2694402A1 Novel polygalacturonases and their uses |
| 01/29/2009 | CA2694397A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694267A1 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 01/29/2009 | CA2694241A1 Cns gene delivery using peripheral administration of aav vectors |
| 01/29/2009 | CA2694205A1 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 01/29/2009 | CA2694006A1 Late blight resistance genes and methods |
| 01/29/2009 | CA2693951A1 Growth hormone fusion proteins |
| 01/29/2009 | CA2693797A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/29/2009 | CA2693305A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | CA2693303A1 Natriuretic polypeptides |
| 01/29/2009 | CA2692777A1 Plants having increased yield-related traits and a method for making the same |
| 01/29/2009 | CA2689099A1 Solubility tags for the expression and purification of bioactive peptides |
| 01/28/2009 | EP2019148A1 Gene mapping method using microsatellite genetic polymorphism markers |
| 01/28/2009 | EP2019145A1 Hematopoietic progenitor cell gene transduction |
| 01/28/2009 | EP2019144A1 Vector particles for targeting CD34+ cells |
| 01/28/2009 | EP2019143A1 CNS gene delivery using peripheral administration of AAV vectors |
| 01/28/2009 | EP2019142A2 Isoforms of elF-5A and methods of using same |
| 01/28/2009 | EP2019141A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019140A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019139A1 WT1 interacting protein WTIP |
| 01/28/2009 | EP2019138A1 Method of constructing gene transport support |
| 01/28/2009 | EP2019137A1 Method for production of cleistogamous rice and method for selection of cleistogamous rice |
| 01/28/2009 | EP2019136A1 Method for detecting or quantifying wheat endogenous dna and method for determining contamination rate of genetically modified wheat in test sample |
| 01/28/2009 | EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/28/2009 | EP2018908A1 Discharge apparatus |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018443A2 Compositions and methods for inhibiting expression of ikk-b gene |
| 01/28/2009 | EP2018436A2 Targeted delivery to leukocytes using non-protein carriers |
| 01/28/2009 | EP2018435A2 Artificial plant minichromosomes |
| 01/28/2009 | EP2018434A1 Method for performing homologous recombination in plants |
| 01/28/2009 | EP2018433A1 Tomato plants having higher levels of resistance to botrytis |
| 01/28/2009 | EP2018432A1 Genetically engineered pseudomonas fluorescens strains as biosensor for trehalose detection and quantification in a sample |
| 01/28/2009 | EP2018431A2 Novel stress-related microrna molecules and uses thereof |
| 01/28/2009 | EP2018430A1 Method for expressing polypeptides in eukaryotic cells using alternative splicing |
| 01/28/2009 | EP2018429A1 Genetically encoded fluorescent coumarin amino acids |
| 01/28/2009 | EP2018428A2 Anti-inflammatory fusion protein |
| 01/28/2009 | EP2018427A2 Delta5 desaturase and its use in making polyunsaturated fatty acids |
| 01/28/2009 | EP2018426A2 Rnai-mediated inhibition of tumor necrosis factor -related conditions |
| 01/28/2009 | EP2018425A1 Method for extracting deoxyribonucleic acids (dna) from microorganisms possibly present in a blood sample |
| 01/28/2009 | EP2018424A2 Methods and compositions for inactivation of dihydrofolate reductase |
| 01/28/2009 | EP2018420A1 Improved gene silencing methods |
| 01/28/2009 | EP2018395A1 Short interference ribonucleic acids for treating allegic diseases |
| 01/28/2009 | EP1861497A4 Protein and its use in diagnosing alzheimer's disease |
| 01/28/2009 | EP1856261A4 Method for preparing transformants expressing benzaldehyde dehydrogenase and prepation of 2,6-naphthalene dicarboxylic acid using the transformants |
| 01/28/2009 | EP1841869A4 Use of atbg1 gene for the generation of transgenic plants with increased resistance to various abiotic stress |
| 01/28/2009 | EP1709181B1 Gene expression technique |
| 01/28/2009 | EP1662863A4 Transgenic tieg non-human animals |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1446426B1 Peptide purification by means of metal ion affinity chromatography |
| 01/28/2009 | EP1391505B1 Stem cells and method of separating the same |
| 01/28/2009 | EP1379658B1 Antimicrobial peptides and methods of use |
| 01/28/2009 | EP1343869B1 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 01/28/2009 | EP1255773B1 Insecticidal proteins from bacillus thuringiensis |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1187939B1 Detection of hiv-1 by nucleic acid amplification |
| 01/28/2009 | EP1015035B1 Vaccination by topical application of genetic vectors |
| 01/28/2009 | EP0675953B1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 01/28/2009 | CN101356436A Treatment and diagnosis of obligate intracellular pathogens |
| 01/28/2009 | CN101356287A Methods and compositions for the assessment of cardiovascular function and disorders |
| 01/28/2009 | CN101356280A Growth of wild-type hepatitis a virus in cell culture |
| 01/28/2009 | CN101356279A DOF (DNA binding with one finger) sequences and methods of use |
| 01/28/2009 | CN101356278A Method for increasing the total oil content in oil plants |
| 01/28/2009 | CN101356277A Nucleic acids and proteins associated with galactomannan synthesis in coffee |
| 01/28/2009 | CN101356276A Micro-spring bombard conversion method for brassica vegetable |
| 01/28/2009 | CN101356275A Recombinant expression of multiprotein complexes using polygenes |
| 01/28/2009 | CN101356274A Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
| 01/28/2009 | CN101356273A Global transcription machinery engineering |
| 01/28/2009 | CN101356272A Microorganisms with increased efficiency for methionine synthesis |
| 01/28/2009 | CN101356271A Identification and discrimination of function interdiction anti-ED-B-fibronectin antibody |
| 01/28/2009 | CN101356270A Nuclear reprogramming factor |
| 01/28/2009 | CN101356269A Methods for expression and purification of recombinant human growth hormone |
| 01/28/2009 | CN101356268A Method for the treatment of retinopathy of prematurity and related retinopathic diseases |
| 01/28/2009 | CN101356188A Plants having improved growth characteristics and a method for making the same |
| 01/28/2009 | CN101355970A Peptide-DICER substrate RNA conjugates as delivery vehicles for SIRNA |
| 01/28/2009 | CN101355960A Mucosal and systemic immunizations with alphavirus replicon particles |
| 01/28/2009 | CN101353706A Adenovirus-transfected primary cells and methods of pathway mapping |
| 01/28/2009 | CN101353700A Genetic marker using MX1 genes as pig production trait and use thereof |
| 01/28/2009 | CN101353696A Biological marker of liver fiber damage including liver fibrosis and/or hepatic cirrhosis and detecting method thereof |
| 01/28/2009 | CN101353671A Preparation and use of recombinant virus vector gene A3G |
| 01/28/2009 | CN101353670A Infectious bovine rhinotracheitis virus recombinant strain, construction method and use thereof |
| 01/28/2009 | CN101353669A Novel plant expression constructs |
| 01/28/2009 | CN101353668A Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof |
| 01/28/2009 | CN101353667A HIV stain drug-resistant phenotype analytical cell model and special pseudotype lentivirus therefor |
| 01/28/2009 | CN101353666A HIV medicament screening cell model and special pseudotype lentivirus therefor |
| 01/28/2009 | CN101353665A DNA vaccine vector expressing hairpin RNA having immune activation function and uses thereof |